Oh good!  Then I'm back to being okay with the dead silence.  okay sarcasm off.

My old eyes got tricked, I went by the Jan 13 NR date. -- Wrong Nr!  My bad.

Quote Charts News Filings Historical News· Filings

News for Resverlogix Corp. (RVX:CA) Sector News | Topic News   $ 0.84   0.01 (+1.20%) Volume: 24.67k 1:38 PM EDT May 11, 2020 View News From :    To:    Page:    of 1   GO  Latest News Tue, Mar 31, 2020 8:00 AM Resverlogix Announces Participation at the American College of Cardiology Scientific Sessions together with the World Congress of Cardiology Virtual - GlobeNewswire Mon, Mar 30, 2020 8:00 AM Resverlogix Announces Publication of Key Apabetalone Study BETonMACE in the Journal of the American Medical Association - GlobeNewswire Tue, Mar 24, 2020 8:00 AM Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication - Thomson Reuters ONE 8:00 AM Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication - GlobeNewswire Mon, Mar 23, 2020 7:00 AM Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research - GlobeNewswire 7:00 AM Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research - Thomson Reuters ONE Mon, Feb 03, 2020 7:30 AM Resverlogix Receives US FDA Breakthrough Therapy Designation for Apabetalone - GlobeNewswire Mon, Jan 13, 2020 9:17 AM CORRECTION: Resverlogix Confirms a Significant Corporate Advancement Establishing Apabetalone as a Potential Blockbuster Combination Drug in High-risk Diabetes Patients with CVD - GlobeNewswire